FilingIndex
10-K/AThe Record

AN2 Therapeutics, Inc. files 10-K/A

Filed May 14, 2024 · 2y ago · Accession 0000950170-24-059488

Plain English

Annual report — full-year financials, business overview, and risk factors.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
ANTX
CIK
1880438
Form type
10-K/A
Filing date
May 14, 2024
Report date
Dec 31, 2023
Document
antx-20231231.htm
Size
1.5 MB